(+)-schisandrin B multiple interactions ISO RGD:1306906 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RPF2 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine multiple interactions ISO RGD:1315788 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPF2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:1315788 6480464 Ethinyl Estradiol results in increased expression of RPF2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:1306906 6480464 Ethinyl Estradiol results in decreased expression of RPF2 mRNA CTD PMID:29097150 17alpha-ethynylestradiol multiple interactions ISO RGD:1315788 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPF2 mRNA CTD PMID:17942748 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of RPF2 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1315788 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPF2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1315788 6480464 Tetrachlorodibenzodioxin affects the expression of RPF2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1315788 6480464 Tetrachlorodibenzodioxin results in increased expression of RPF2 mRNA CTD PMID:17942748 2,4-dinitrotoluene affects expression ISO RGD:1306906 6480464 2, 4-dinitrotoluene affects the expression of RPF2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO RGD:1306906 6480464 2, 6-dinitrotoluene affects the expression of RPF2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression EXP 6480464 Lactic Acid results in increased expression of RPF2 mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of RPF2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of RPF2 mRNA CTD PMID:28628672 4-amino-2,6-dinitrotoluene affects expression ISO RGD:1306906 6480464 4-amino-2, 6-dinitrotoluene affects the expression of RPF2 mRNA CTD PMID:21346803 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of RPF2 mRNA CTD PMID:27153756 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of RPF2 mRNA CTD PMID:23724009 arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RPF2 protein] CTD PMID:26598702 benzo[a]pyrene increases expression ISO RGD:1315788 6480464 Benzoapyrene results in increased expression of RPF2 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:19150397 bisphenol A increases expression ISO RGD:1306906 6480464 bisphenol A results in increased expression of RPF2 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of RPF2 mRNA CTD PMID:30903817 carbon nanotube increases expression ISO RGD:1315788 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chloropicrin increases expression EXP 6480464 chloropicrin results in increased expression of RPF2 mRNA CTD PMID:26352163 chromium(6+) affects expression ISO RGD:1315788 6480464 chromium hexavalent ion affects the expression of RPF2 mRNA CTD PMID:28472532 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of RPF2 mRNA CTD PMID:27392435 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of RPF2 mRNA CTD PMID:19549813 coumestrol increases expression EXP 6480464 Coumestrol results in increased expression of RPF2 mRNA CTD PMID:19167446 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of RPF2 mRNA CTD PMID:20106945 , PMID:25562108 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of RPF2 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RPF2 protein] CTD PMID:26598702 dibutyl phthalate decreases expression ISO RGD:1315788 6480464 Dibutyl Phthalate results in decreased expression of RPF2 mRNA CTD PMID:21266533 dioxygen multiple interactions ISO RGD:1315788 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RPF2 mRNA CTD PMID:30529165 disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of RPF2 mRNA CTD PMID:18175754 endosulfan increases expression ISO RGD:1306906 6480464 Endosulfan results in increased expression of RPF2 mRNA CTD PMID:29391264 flutamide increases expression ISO RGD:1306906 6480464 Flutamide results in increased expression of RPF2 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1315788 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPF2 mRNA CTD PMID:22206623 furan increases methylation ISO RGD:1306906 6480464 furan results in increased methylation of RPF2 gene CTD PMID:22079235 glafenine increases expression ISO RGD:1306906 6480464 Glafenine results in increased expression of RPF2 mRNA CTD PMID:24136188 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of RPF2 mRNA CTD PMID:28628672 ketamine decreases expression ISO RGD:1306906 6480464 Ketamine results in decreased expression of RPF2 mRNA CTD PMID:20080153 methylparaben decreases expression EXP 6480464 methylparaben results in decreased expression of RPF2 mRNA CTD PMID:31745603 oxaliplatin multiple interactions ISO RGD:1306906 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RPF2 mRNA CTD PMID:25729387 paracetamol increases expression ISO RGD:1315788 6480464 Acetaminophen results in increased expression of RPF2 mRNA CTD PMID:17585979 pentachlorophenol increases expression ISO RGD:1315788 6480464 Pentachlorophenol results in increased expression of RPF2 mRNA CTD PMID:23892564 perfluorononanoic acid increases expression EXP 6480464 perfluorononanoic acid results in increased expression of RPF2 mRNA CTD PMID:32588087 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of RPF2 mRNA CTD PMID:19159669 pirinixic acid increases expression ISO RGD:1315788 6480464 pirinixic acid results in increased expression of RPF2 mRNA CTD PMID:18301758 rac-lactic acid increases expression EXP 6480464 Lactic Acid results in increased expression of RPF2 mRNA CTD PMID:30851411 resveratrol decreases expression ISO RGD:1315788 6480464 resveratrol results in decreased expression of RPF2 protein CTD PMID:25505154 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of RPF2 mRNA CTD PMID:25895662 sodium dichromate increases expression ISO RGD:1306906 6480464 sodium bichromate results in increased expression of RPF2 mRNA CTD PMID:25993096 sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of RPF2 mRNA CTD PMID:31533062 tetrachloromethane increases expression ISO RGD:1315788 6480464 Carbon Tetrachloride results in increased expression of RPF2 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane increases expression ISO RGD:1306906 6480464 Carbon Tetrachloride results in increased expression of RPF2 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:1306906 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RPF2 mRNA] CTD PMID:31150632 titanium dioxide decreases expression ISO RGD:1315788 6480464 titanium dioxide results in decreased expression of RPF2 mRNA CTD PMID:29264374 topotecan multiple interactions ISO RGD:1306906 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RPF2 mRNA CTD PMID:25729387 trimellitic anhydride increases expression ISO RGD:1315788 6480464 trimellitic anhydride results in increased expression of RPF2 mRNA CTD PMID:19042947 Triptolide increases expression ISO RGD:1306906 6480464 triptolide results in increased expression of RPF2 protein CTD PMID:32519852 tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of RPF2 mRNA CTD PMID:22378314 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of RPF2 mRNA CTD PMID:29154799 valproic acid decreases expression ISO RGD:1315788 6480464 Valproic Acid results in decreased expression of RPF2 mRNA CTD PMID:21427059 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of RPF2 mRNA CTD PMID:25979313 vinclozolin decreases expression ISO RGD:1306906 6480464 vinclozolin results in decreased expression of RPF2 mRNA CTD PMID:23034163